• DOI:10.1515/hmbci.2010.010
Corpus ID: 28578077

The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids

@inproceedings{Dukov2010TheIO,
  title={The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids},
  author={M. Du{\vs}kov{\'a} and M. Hill and Ľ. St{\'a}rka},
  booktitle={Hormone molecular biology and clinical investigation},
  year={2010}
}

M. Dušková, M. Hill, Ľ. Stárka

Published in

Hormone molecular biology and…

2010

Biology, Medicine

Abstract Background: Finasteride is a 5α-reductase inhibitor that has received clinical approval for the treatment of human benign prostatic hyperplasia and androgenetic alopecia. The treatment is practically without side effects, although some occasional cases of depression syndrome have been reported. 5α-Reductase is an enzyme responsible for the reduction of testosterone, progesterone or deoxycorticosterone to their 5α-reduced derivatives possessing anticonvulsant, antidepressant, and… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed